MEDP director Robert O. Kraft records 57 RSUs vested

Rhea-AI Filing Summary

Robert O. Kraft, a director of Medpace Holdings, Inc. (MEDP), reported a securities transaction on 09/30/2025. The filing shows 57 restricted stock units vested and were reported as delivered, arising from a 227-unit grant made on 11/29/2024 that vests in four approximately equal installments on 03/31/2025, 06/30/2025, 09/30/2025 and 12/31/2025. Each restricted stock unit represents the right to receive one share of MEDP common stock. After the reported transaction the form lists 833 shares of common stock beneficially owned by the reporting person.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Kraft Robert O.

(Last) (First) (Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)

CINCINNATI OH 45227

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		M		57	A	(1)	833	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	09/30/2025		M			57	(2)	(2)	Common Stock	57	$0	56	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

2. On November 29, 2024, the Reporting Person was granted 227 restricted stock units vesting in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025.

Remarks:

	/s/ Stephen P. Ewald, Attorney-in-Fact for Robert O. Kraft	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Medpace (MEDP) insider Robert O. Kraft report on 09/30/2025?

The filing reports the vesting and delivery of 57 restricted stock units on 09/30/2025 from a 227-unit grant made on 11/29/2024.

How many restricted stock units were originally granted to Robert O. Kraft?

The reporting person was granted 227 restricted stock units on 11/29/2024, vesting in four approximately equal installments.

How many shares does Robert O. Kraft beneficially own after the transaction?

The Form 4 lists 833 shares of common stock beneficially owned following the reported transactions.

What is the conversion relationship between the restricted stock units and common stock?

Each restricted stock unit represents a contingent right to receive one share of MEDP common stock, per the filing.

Was any cash paid for the restricted stock units on vesting?

The Form 4 shows the price as $0 for the delivered restricted stock units, indicating no cash price on vesting in this entry.